ADIPOQ and steatosis: Steatosis was assessed by the controlled attenuation parameter (CAP) obtained via transient elastography, and the participants were grouped as  ̈Non-Steatosis ̈ (n = 24) and  ̈Steatosis ̈ (n = 14).<h4>Results</h4>The "Steatosis group" showed higher BP (Z SBP 1.56 vs. -0.25; Z DBP 1.38 vs. 0.07; p = 0.0001), BMI (z-BMI 3.48 vs. 2.39; p < 0.0001), right CIMT (0.07 vs. 0.06 cm; p = 0.013), basal insulin (41 vs. 14 mcUI/l; p < 0.0001), and HOMA-IR (8.2 vs. 3.1; p < 0.0001), and lower adiponectin (2.75 vs. 6.46 μg/ml; p = 0.004) compared to the "Non-Steatosis" group even after z-BMI adjustments.